Abstract:Microbial resistance and other emerging health risk problems related to the side effects of synthetic drugs are the major factors that result in the research regarding natural products. Fruits, leaves, seeds, and oils-based phyto-constituents are the most important source of pharmaceutical products. Plant extract chemistry depends largely on species, plant components, solvent utilized, and extraction technique. This study was aimed to compare the ethanolic extracts of a mangrove plant, i.e., Avicennia marina (1E: Lower half of A. marina's pneumatophores, 2E: A. marina's leaves, 3E: Upper half of A. marina's pneumatophores, and 4E: A. marina's shoots), with non-mangrove plants, i.e., Phragmites australis (5E: P. australis's shoot), and Moringa oleifera (6E: M. oleifera's leaves) for their antimicrobial activities, total phenolic contents, antioxidant activity, and cytotoxicity potential. The antimicrobial activity assays were performed on gram-positive bacteria (i.e., Bacillus subtilis and Staphylococcus aureus), gram-negative bacteria (i.e., Escherichia coli, and Pseudomonas aeruginosa), and fungi (i.e., Aspergillus niger, Candida albicans, and Rhizopus spp.). We estimated antioxidant activity by TAC, DPPH, and FRAP assays, and the cytotoxicity was evaluated by MTT assay. The results of antimicrobial activities revealed that B. subtilis was the most sensitive to the tested plant extracts compared to S. aureus, while it only showed sensitivity to 6E and Imipenem. 5E and 6E showed statistically similar results against P. aeruginosa as compared to Ceftazidime. E. coli was the most resistant bacteria against tested plant extracts. Among the tested plant extracts, maximum inhibition activity was observed by 6E against A. niger (22 ± 0.57 mm), which was statistically similar to the response of 6E against C. albicans and 3E against Rhizopus spp. 2E did not show any activity against tested fungi. We found that 6E (208.54 ± 1.92 mg g-1) contains maximum phenolic contents followed by 1E (159.42 ± 3.22 mg g-1), 5E (131.08 ± 3.10 mg g-1), 4E (i.e., 72.41 ± 2.96 mg g-1), 3E (67.41 ± 1.68 mg g-1), and 2E (48.72 ± 1.71 mg g-1). The results depict a significant positive correlation between the phenolic contents and the antioxidant activities. As a result, phenolic content may be a natural antioxidant source.

Discovery of secondary metabolites from Avicennia marina to inhibit the anti-oxidant and anti-biofilm activities of biofilm forming bacteria

Antimicrobial Activity Avicennia marina Flowers

Phytochemical composition of Avicennia marina leaf extract, its antioxidant, antimicrobial potentials and inhibitory properties on Pseudomonas fluorescens biofilm

Phytochemical analysis of the methanolic extract from the mangrove species Avicennia marina plant species inhabited in coastal water

Antibacterial and Antifungal Activity of the Extracts of Different Parts of Avicennia marina (Forssk.) Vierh

Biological Activities of Avicennia marina Roots and Leaves Regarding Their Chemical Constituents

Comparative study among Avicennia marina, Phragmites australis, and Moringa oleifera based ethanolic-extracts for their antimicrobial, antioxidant, and cytotoxic activities

Molecular Characterization and Antibacterial Potential of Endophytic Fungal Isolates from Selected Mangroves along the Coastline of Kenya

Anticancer and anti-inflammatory activity and untargeted metabolite profiling by UPLC-ESI-QTOF of crude extracts of mangrove endophytic fungus Aspergillus stellatus LM-03

Antimicrobial Secondary Metabolites from the Mangrove Plants of Asia and the Pacific

Anti-Periodontopathogenic Ability of Mangrove Leaves (Aegiceras corniculatum) Ethanol Extract: In silico and in vitro study

Isolation and screening of antimicrobial biosurfactants obtained from mangrove plant root-associated bacteria

Phyco-chemical and compound analysis from the macro algae, Sargassum ilicifolium and its antibiofilm, antioxidants and Aedes aegypti mosquito larvicidal propensities

Three New Isoflavonoid Glycosides From The Mangrove-Derived Actinomycete Micromonospora Aurantiaca 110b

Network pharmacology-based screening of active constituents of Avicennia marina and their clinical biochemistry related mechanism against breast cancer

Fungal endophytes from leaves of Avicennia marina growing in semi‐arid environment as a promising source for bioactive compounds

Multi-functional bioactive secondary metabolites derived from endophytic fungi of marine algal origin

Investigating the antimicrobial and antibiofilm properties of marine halophilic Bacillus species against ESKAPE pathogens

In vitro antioxidant, antibacterial, and antihyperlipidemic potential of ethanolic Avicennia marina leaves extract supported by metabolic profiling

Evaluation of antibacterial potential of mangrove sediment-derived actinomycetes

Anti-quorum sensing and biofilm inhibitory effect of some medicinal plants against gram-negative bacterial pathogens: in vitro and in silico investigations